Aurinia Pharmaceuticals Inc (AUPH)
$16.65 -3.25% Close Oct 30, 2026 Live
Aurinia Pharmaceuticals stock today
Aurinia Pharmaceuticals closed at $16.65 on October 30, 2026, down 3.25% on the day. Over the past year it returned +37.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.14 billion.
$12.00$14.00$16.00$18.00
NovJan 2026MarMayJulSep
| Period | AUPH | S&P 500 (SPY) |
|---|---|---|
| 1 month | +2.8% | -0.9% |
| 3 months | +11.0% | +2.1% |
| Year to date | +4.4% | +11.7% |
| 1 year | +37.4% | +12.4% |
| 3 years | +126.5% | +88.5% |
| 5 years | -49.7% | +76.0% |
Key statistics
- Market value
- $2.14B
- P/E (trailing)
- 7.3
- Forward P/E
- 15.0
- Price / sales
- 6.9
- 52-week range
- $12.12 to $18.62
About Aurinia Pharmaceuticals
Develops and commercializes pharmaceutical therapies for kidney and immunological diseases.
Sector: Health Care
More on Aurinia Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +20% in the year to Dec 2025
- Valuation: P/E history and peersP/E 7.3
- Returns: what $1,000 became$1,000 ten years ago is $5,155 today
No forecast, no recommendation. This page describes Aurinia Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.